- Report
- May 2025
- 199 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 191 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 190 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 188 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 187 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 194 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- May 2025
- 180 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- April 2025
- 138 Pages
Global
From €2633EUR$2,999USD£2,259GBP
- Report
- April 2025
- 120 Pages
Global
From €5223EUR$5,950USD£4,482GBP
- Report
- February 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,482GBP
- Report
- February 2025
- 316 Pages
Global
From €3950EUR$4,500USD£3,390GBP
- Report
- July 2025
- 278 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- January 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- July 2025
- 283 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- July 2025
- 377 Pages
Global
From €5135EUR$5,850USD£4,407GBP

Biomarker validation is the process of determining the accuracy and reliability of a biomarker for use in medical research and diagnostics. It involves the evaluation of the biomarker's ability to accurately measure a biological process or disease state, as well as its ability to predict the outcome of a medical intervention. The validation process typically includes laboratory testing, clinical trials, and statistical analysis.
The biomarker validation market is a rapidly growing sector of the biotechnology industry, driven by the increasing demand for personalized medicine and the need for more accurate and reliable biomarkers. Companies in this market are focused on developing and validating biomarkers for a variety of diseases and conditions, including cancer, cardiovascular disease, and neurological disorders.
Some of the major companies in the biomarker validation market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more